20 reports

  • PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS

HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* HEART TRANSPLANT REJECTION

  • Clinical Trial
  • Heart Transplant
  • Immunology
  • Pharmaceutical
  • Novartis AG

CLINICAL TRIALS BY PHASE IN G## COUNTRIES LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* LUNG TRANSPLANT REJECTION THERAPEUTICS, G## COUNTRIES, CLINIC

  • Clinical Trial
  • Immunology
  • Lung Transplant
  • Monoclonal Antibody
  • Novartis AG
  • Target
  • 5. All the trials included are unique trials.

Reddy' s Under Fasting Conditions GDCT## NCT##, BA## Immunology Heart Transplant Rejection, Kidney Transplant Rejection, Liver Transplant Rejection Completed Phase I Interventional tacrolimus Dr.

  • Clinical Trial
  • Immunology
  • Monoclonal Antibody
  • Transplantation
  • Novartis AG

Reddy' s Under Fasting Conditions GDCT## NCT##, BA## Immunology Heart Transplant Rejection, Kidney Transplant Rejection, Liver Transplant Rejection Completed Phase I Interventional tacrolimus Dr.

  • Clinical Trial
  • Immunology
  • Liver Transplant
  • Transplantation
  • Novartis AG

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## Alexion Pharmaceuticals Inc ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## Cytokinetics Inc ## ## ## ## ## ## ## Quintiles IMS Holdings Inc ## ## ## ## ## ## ## CuraVac Inc ## ## ## ## ## ## ## CSL Ltd ##

  • Clinical Trial
  • Immunology
  • Monoclonal Antibody
  • World
  • Product Initiative

Hoffmann-La Roche Ltd arGEN-X BV ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Applied BioMath LLC ## ## ## ## ## Amgen Inc ## ## ## ## ## Almirall SA Source: GlobalData' s Pharma Intelligence C

  • Autoimmune Disease
  • Immunology
  • Medical Biotechnology
  • World
  • Product Initiative
  • Clinical Trial profile. 1115 Trial Title
  • Clinical Trial profile. 1 Trial Title

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Immunology
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • World

Hoffmann-La Roche Ltd ## ## ## ## ## ## Zenyaku Kogyo Co Ltd ## ## ## ## ## ## Syntimmune Inc ## ## ## ## ## ## Principia Biopharma Inc ## ## ## ## ## ## Pharmaceutical Product Development LLC ## ## ## ## ## ## Caduceus Pharma Ltd ## ## ## ## ## ## Amgen Inc ## ## ## ## ##

  • Clinical Trial
  • Hospital
  • Immunology
  • World
  • Product Initiative

In the study, ## patients were randomized ##:##:## to receive placebo, baricitinib ## mg or baricitinib ## mg.

  • Immunology
  • Medical Biotechnology
  • Musculoskeletal Disorder
  • World
  • GlaxoSmithKline plc
  • Clinical Trial profile. 791 Trial Title

(Stage ##) and s. c.

  • Autoimmune Disease
  • Immunology
  • Medical Biotechnology
  • Pharmaceutical
  • World

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## C.

  • Clinical Trial
  • Immunology
  • Medical Biotechnology
  • World
  • Product Initiative

(Stage ##) and s. c.

  • Autoimmune Disease
  • Immunology
  • Pharmaceutical
  • Therapy
  • World
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, TABLE OF ALL CLINICAL STAGE PIPELINE PRODUCTS, 2018, PART 9

Heart transplant. https:/ / www. nhs. uk/ conditions/ heart-transplant/ [Accessed on November ##, 2017] Norman DJ and Leone MR (1991).

  • Healthcare
  • Immunology
  • Monoclonal Antibody
  • Company Financials
  • Forecast

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## ## ## UCB SA ## ## ## ## ## ## ## ## Celgene Corp ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Q

  • Clinical Trial
  • Immunology
  • Therapy
  • World
  • GlaxoSmithKline plc

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Clinical Trial profile. 665 Trial Title

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Neopharm Ltd ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Bellicum Pharmaceutic

  • Drug Development
  • Immunology
  • Pharmaceutical
  • Transplantation
  • World

The company markets AlloMap heart transplant molecular test, a gene expression test which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients.

  • Cancer
  • Healthcare
  • Immunology
  • Corporate Finance
  • Illumina, Inc.

The company markets AlloMap heart transplant molecular test, a gene expression test which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients.

  • Cancer
  • Healthcare
  • Immunology
  • Corporate Finance
  • Illumina, Inc.

CYCLOSPORINE, MARKETED AS NEORAL, IS AN IMMUNOSUPPRESSANT DEVELOPED BY NOVARTIS FOR THE PREVENTION OF ORGAN REJECTION FOLLOWING KIDNEY, LIVER OR HEART TRANSPLANTATION.

  • Immunology
  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • Novartis AG

CYCLOSPORINE, MARKETED AS NEORAL, IS AN IMMUNOSUPPRESSANT DEVELOPED BY NOVARTIS FOR THE PREVENTION OF ORGAN REJECTION FOLLOWING KIDNEY, LIVER OR HEART TRANSPLANTATION.

  • Immunology
  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • Novartis AG